These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6771803)

  • 1. Further studies on the mechanism of serotonin-dependent anorexia in rats.
    Samanin R; Caccia S; Bendotti C; Borsini F; Borroni E; Invernizzi R; Pataccini R; Mennini T
    Psychopharmacology (Berl); 1980; 68(1):99-104. PubMed ID: 6771803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anorexia and brain serotonin: development of tolerance to the effects of fenfluramine and quipazine in rats with serotonin-depleting lesions.
    Carlton J; Rowland N
    Pharmacol Biochem Behav; 1984 May; 20(5):739-45. PubMed ID: 6610879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chlorophenylpiperazine: a central serotonin agonist causing powerful anorexia in rats.
    Samanin R; Mennini T; Ferraris A; Bendotti C; Borsini F; Garattini S
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Aug; 308(2):159-63. PubMed ID: 503247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that it is possible to cause anorexia by increasing release and/or directly stimulating postsynaptic serotonin receptors in the brain.
    Samanin R; Mennini T; Garattini S
    Prog Neuropsychopharmacol; 1980; 4(4-5):363-9. PubMed ID: 7220662
    [No Abstract]   [Full Text] [Related]  

  • 5. Du 24565, a quipazine derivative, a potent selective serotonin uptake inhibitor.
    Vaatstra WJ; Deiman-Van Aalst WM; Eigeman L
    Eur J Pharmacol; 1981 Mar; 70(2):195-202. PubMed ID: 6973481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurochemical mechanism of action of drugs which modify feeding via the serotoninergic system.
    Garattini S; Mennini T; Bendotti C; Invernizzi R; Samanin R
    Appetite; 1986; 7 Suppl():15-38. PubMed ID: 2427023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From fenfluramine racemate to d-fenfluramine. Specificity and potency of the effects on the serotoninergic system and food intake.
    Garattini S; Mennini T; Samanin R
    Ann N Y Acad Sci; 1987; 499():156-66. PubMed ID: 2440376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of fenfluramine and fluoxetine anorexia by 8-OH-DPAT is attenuated following raphe injection of 5,7-dihydroxytryptamine.
    Currie PJ; Coscina DV; Fletcher PJ
    Brain Res; 1998 Jul; 800(1):62-8. PubMed ID: 9685586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin2 receptor agonists and serotonergic anorectic drugs affect rats' performance differently in a five-choice serial reaction time task.
    Carli M; Samanin R
    Psychopharmacology (Berl); 1992; 106(2):228-34. PubMed ID: 1532259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of quipazine on 5-HT metabolism in the rat brain.
    Hamon M; Bourgoin S; Enjalbert A; Bockaert J; Hery F; Ternaux JP; Glowinski J
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Jul; 294(1):99-108. PubMed ID: 1004632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A neuropharmacological analysis of the discriminative stimulus properties of fenfluramine.
    White FJ; Appel JB
    Psychopharmacology (Berl); 1981; 73(2):110-5. PubMed ID: 6785800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sleep suppressant action of fenfluramine in rats. II. Evidence against the involvement of presynaptic serotonergic mechanism.
    Fornal C; Radulovacki M
    J Pharmacol Exp Ther; 1983 Jun; 225(3):675-81. PubMed ID: 6223135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonism of fenfluramine-induced hyperthermia in rats by some, but not all, selective inhibitors of 5-hydroxytryptamine uptake.
    Sugrue MF
    Br J Pharmacol; 1984 Apr; 81(4):651-7. PubMed ID: 6722394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective reduction by serotonergic agents of hypertonic saline consumption in rats: evidence for possible 5-HT1C receptor mediation.
    Neill JC; Cooper SJ
    Psychopharmacology (Berl); 1989; 99(2):196-201. PubMed ID: 2508154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for 5-HT2 receptor mediation in quipazine anorexia.
    Shukla R; MacKenzie-Taylor D; Rech RH
    Psychopharmacology (Berl); 1990; 100(1):115-8. PubMed ID: 2296618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain-to-blood partition and in vivo inhibition of 5-hydroxytryptamine reuptake and quipazine-mediated behaviour of nefazodone and its main active metabolites in rodents.
    Nacca A; Guiso G; Fracasso C; Cervo L; Caccia S
    Br J Pharmacol; 1998 Dec; 125(7):1617-23. PubMed ID: 9884092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Citalopram: a new potent inhibitor of serotonin (5-HT) uptake with central 5-HT-mimetic properties.
    Pawłowski L; Ruczyńska J; Górka Z
    Psychopharmacology (Berl); 1981; 74(2):161-5. PubMed ID: 6267647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of food intake by manipulation of central serotonin. Current experimental results.
    Garattini S; Mennini T; Samanin R
    Br J Psychiatry Suppl; 1989 Dec; (8):41-51. PubMed ID: 2692639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mCPP but not TFMPP is an antagonist at cardiac 5HT3 receptors.
    Robertson DW; Bloomquist W; Wong DT; Cohen ML
    Life Sci; 1992; 50(8):599-605. PubMed ID: 1736030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amitriptyline and femoxetine, but not clomipramine or citalopram, antagonize hyperthermia induced by directly acting 5-hydroxytryptamine-like drugs in heat adapted rats.
    Pawłowski L
    J Pharm Pharmacol; 1984 Mar; 36(3):197-9. PubMed ID: 6144758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.